These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18407764)

  • 21. A novel pairwise comparison method for in silico discovery of statistically significant cis-regulatory elements in eukaryotic promoter regions: application to Arabidopsis.
    Shamloo-Dashtpagerdi R; Razi H; Aliakbari M; Lindlöf A; Ebrahimi M; Ebrahimie E
    J Theor Biol; 2015 Jan; 364():364-76. PubMed ID: 25303887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Gene Ther; 2007 Feb; 14(4):292-303. PubMed ID: 17024105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adeno-associated virus-vectored gene therapy for retinal disease.
    Dinculescu A; Glushakova L; Min SH; Hauswirth WW
    Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of modular and pleiotropic enhancers.
    Murugesan SN; Monteiro A
    J Exp Zool B Mol Dev Evol; 2023 Mar; 340(2):105-115. PubMed ID: 35334158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
    Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
    PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local and systemic responses following intravitreous injection of AAV2-encoded modified Volvox channelrhodopsin-1 in a genetically blind rat model.
    Sugano E; Tabata K; Takahashi M; Nishiyama F; Shimizu H; Sato M; Tamai M; Tomita H
    Gene Ther; 2016 Feb; 23(2):158-66. PubMed ID: 26440056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.
    Flannery JG; Visel M
    Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression.
    Real G; Monteiro F; Burger C; Alves PM
    Appl Microbiol Biotechnol; 2011 Sep; 91(6):1581-91. PubMed ID: 21674167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element.
    Wang L; Wang Z; Zhang F; Zhu R; Bi J; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
    Int J Med Sci; 2016; 13(4):286-91. PubMed ID: 27076785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
    Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
    Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells.
    Langouet-Astrie CJ; Yang Z; Polisetti SM; Welsbie DS; Hauswirth WW; Zack DJ; Merbs SL; Enke RA
    Exp Eye Res; 2016 Oct; 151():61-7. PubMed ID: 27481653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retroviral vectors for high-level transgene expression in T lymphocytes.
    Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
    Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dog models for blinding inherited retinal dystrophies.
    Petersen-Jones SM; Komáromy AM
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):15-26. PubMed ID: 25671556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness.
    Scalabrino ML; Boye SL; Fransen KM; Noel JM; Dyka FM; Min SH; Ruan Q; De Leeuw CN; Simpson EM; Gregg RG; McCall MA; Peachey NS; Boye SE
    Hum Mol Genet; 2015 Nov; 24(21):6229-39. PubMed ID: 26310623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.
    Powell SK; Rivera-Soto R; Gray SJ
    Discov Med; 2015 Jan; 19(102):49-57. PubMed ID: 25636961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy in inherited retinal degenerative diseases, a review.
    Takahashi VKL; Takiuti JT; Jauregui R; Tsang SH
    Ophthalmic Genet; 2018 Oct; 39(5):560-568. PubMed ID: 30040511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput cis-regulatory element discovery in the vector mosquito Aedes aegypti.
    Behura SK; Sarro J; Li P; Mysore K; Severson DW; Emrich SJ; Duman-Scheel M
    BMC Genomics; 2016 May; 17():341. PubMed ID: 27161480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element.
    Haberman RP; McCown TJ; Samulski RJ
    J Virol; 2000 Sep; 74(18):8732-9. PubMed ID: 10954575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.